EWA
IMVT icon

EverSource Wealth Advisors’s Immunovant IMVT Stock Holding History

EverSource Wealth Advisors’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.9K Buy
479
+192
+67% +$4.97K ﹤0.01% 2824
2025
Q4 		$7.3K Buy
287
+242
+538% +$5.4K ﹤0.01% 2949
2025
Q3 		$726 Buy
45
+29
+181% +$469 ﹤0.01% 3843
2025
Q2 		$256 Sell
16
-187
-92% -$2.83K ﹤0.01% 4023
2025
Q1 		$3.47K Buy
203
+186
+1,094% +$3.89K ﹤0.01% 2669
2024
Q4 		$421 Buy
17
+3
+21% +$85 ﹤0.01% 3253
2024
Q3 		$399 Hold
14
– – ﹤0.01% 2908
2024
Q2 		$407 Buy
14
+11
+367% +$313 ﹤0.01% 2931
2024
Q1 		$82 Buy
+3
New +$109 ﹤0.01% 2831

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return